Cikarang, Indonesia

Our Production Facility

With various modern product facilities to support the needs in the process of making medicinal raw materials.

This is our production facility

PT Kimia Farma Sungwun Pharmacopia, hereinafter abbreviated as KFSP, has industry 4.0-based production facilities. KFSP has also been equipped with sophisticated testing laboratory facilities to support and maintain the quality of the raw materials produced.

KFSP has several production facilities; API Production (Class E GMP), Non-API Production (Class F GMP), Povidone Iodine Production, ARV Production and Paracetamol Production Facility (coming soon). Those facilities are equipped with sophisticated reactors with capacity ranging from 100 litres to 5000 metres cubic each reactor. Annual capacity of KFSP Production Facilities were 74 MT for API Production and 168 MT for Non-API Production.

In order to ensure and maintain the quality of the products, KFSP has 2 laboratories, namely a use test laboratory and an analysis laboratory. Each laboratory is equipped with sophisticated instruments

KFSP also has several warehouses to store products and raw materials. Product and raw material storage are also equipped with proper temperature and humidity control settings to support and maintain products qualities.

Our Product Timeline


Atorvastatin Calcium Trihydrate; Simvastatin; Clopidogrel Bisulphate


Entecavir Monohydrate; Efavirenz; Lauroyl Lysine; Palmitic Acid Mixture Series; Cholesterol Nonanoate


Zidovudine; Lamivudine; Tenofovir Disoproxil Fumarate; Rosuvastatin; Remdesivir; Cholesteryl Chloride